More on ELVN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/7/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Enliven Therapeutics, Inc (NQ:ELVN)
Delayed: 29.44 +0.15 (0.51%)
Prev. Close $29.29  
Open$28.68 
52 Wk High$ 
52 Wk Low$ 
Day High$30.02 
Day Low$27.95 
P/E N/A  
EPS$ 
Volume564,053 

Friends, Peers and Foes (?): ALLO, CHRS, ONCY PYXS (more...)

Mar 6, 2026 04:07 PM Form 144 Enliven Therapeutics, Filed by: Hohl Benjamin
Mar 3, 2026 05:21 PM Form S-8 Enliven Therapeutics,
Mar 3, 2026 04:36 PM Enliven Therapeutics, Inc (ELVN) Misses Q4 EPS by 2c
Mar 3, 2026 04:21 PM Form 10-K Enliven Therapeutics, For: Dec 31
Mar 3, 2026 04:15 PM Form 8-K Enliven Therapeutics, For: Mar 03
Mar 3, 2026 04:05 PM Enliven Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Feb 25, 2026 04:05 PM Enliven Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
Feb 19, 2026 06:39 PM Form 4 Enliven Therapeutics, For: Feb 17 Filed by: Heyman Richard A.
Feb 19, 2026 06:37 PM Form 4 Enliven Therapeutics, For: Feb 17 Filed by: Collins Helen Louise
Feb 18, 2026 04:25 PM Form 144 Enliven Therapeutics, Filed by: Lyssikatos Joseph P
View All Articles

Entities mentioned with ELVN

View All Entities